Germantown, MD, United States of America

Margaret Stauber

This inventor holds 1 USPTO granted patent. Top assignees: Rutgers, The State University of New Jersey, University of California. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Margaret Stauber

Introduction

Margaret Stauber is a notable inventor based in Germantown, MD (US). She has made significant contributions to the field of antiviral methods, particularly in the fight against HIV. Her work has the potential to impact the lives of many individuals affected by this virus.

Latest Patents

Margaret Stauber holds a patent for "Naphthols useful in antiviral methods." This invention relates to a novel class of compounds that serve as potent inhibitors of HIV reverse transcriptase and HIV integrase. The compounds are remarkable for their non-toxicity to cells at typical therapeutic concentrations and their effectiveness against mutant strains of HIV reverse transcriptase. This makes them ideal candidates for use in combination with existing therapies or as standalone treatments for AIDS or HIV infection.

Career Highlights

Throughout her career, Margaret Stauber has worked with prestigious institutions such as the University of California and Rutgers, The State University of New Jersey. Her research has focused on developing innovative solutions to combat viral infections, showcasing her dedication to advancing medical science.

Collaborations

Margaret has collaborated with notable colleagues, including Todd J Ewing and Angelika Muscate. These partnerships have contributed to her success and the advancement of her research in antiviral methods.

Conclusion

Margaret Stauber's innovative work in developing antiviral compounds highlights her significant contributions to medical science. Her research not only addresses the challenges posed by HIV but also opens new avenues for treatment options.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…